Tag Archives: urothelial carcinoma

November, 2018

August, 2018

May, 2017

April, 2017

February, 2017

  • 3 February

    FDA Approves Bristol-Myers Squibb’s Opdivo for Treatment of Bladder Cancer

    PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for intravenous use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 …

June, 2016

March, 2016